| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 02, 2026 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$213.00
Est. +32%
|
$161.00 | $169.57 |
Pending
|
$159.51
-0.9%
|
| Apr 24, 2026 |
Altimmune Inc
ALT
|
SELL |
$2.50
Est. +13%
|
$2.89 | $2.56 (Low) |
Precision Hit (±3%)
|
$2.64
+8.7%
|
| Oct 17, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$139.00
Est. +25%
|
$111.18 | $122.20 |
Pending
|
$89.70
-19.3%
|
| Jul 10, 2025 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$33.00
Est. +50%
|
$22.03 | $33.62 |
Precision Hit (±3%)
|
$30.54
+38.6%
|
| Jul 10, 2025 |
Harmony Biosciences Holdings Inc
HRMY
|
SELL |
$33.00
Est. +4%
|
$34.33 | $25.52 (Low) |
Target Met
|
$34.18
+0.4%
|
| Jul 10, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$97.00
Est. +9%
|
$89.04 | $122.20 |
Target Met
|
$89.70
+0.7%
|
| Jul 10, 2025 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$18.00
Est. +83%
|
$9.82 | $25.58 |
Target Met
|
$18.48
+88.2%
|
| Sep 24, 2024 |
Avidity Biosciences Inc
RNA
|
BUY |
$59.00
Est. +36%
|
$43.50 | $55.98 |
Miss
|
$12.75
-70.7%
|
| Sep 16, 2024 |
Cg Oncology Inc.
CGON
|
BUY |
$52.00
Est. +49%
|
$34.80 | $40.47 |
Miss
|
$59.56
+71.1%
|
| May 13, 2024 |
Cg Oncology Inc.
CGON
|
BUY |
$50.00
Est. +93%
|
$25.84 | $40.47 |
Miss
|
$59.56
+130.5%
|
| Mar 13, 2024 |
Immunovant Inc
IMVT
|
BUY |
$50.00
Est. +57%
|
$31.82 | $34.47 |
Miss
|
$33.44
+5.1%
|